Carvolix secures new €10M tranche, bringing total financing to €20M

Funding
Carvolix has raised an additional €10 million tranche, bringing total funding under its €30 million financing programme to €20 million. The new capital reflects continued support from existing strategic shareholders and is intended to...

Carvolix secures new €10M tranche, bringing total financing to €20M

Funding
Carvolix has raised an additional €10 million tranche, bringing total funding under its €30 million financing programme to €20 million. The new capital reflects...

Tissium closes $68M financing for tissue reconstruction polymers

Funding
Tissium has raised $68 million (€60 million) through a combination of a $34 million Series D2 financing and a $34 million financing facility from...

Valgen earns CE mark for mitral valve repair system

Regulatory Approvals
Valgen Medtech has received CE mark approval for its DragonFly transcatheter mitral valve repair system for the treatment of functional mitral regurgitation (FMR), expanding...

AorticLab earns expanded CE mark for embolic protection device

Regulatory Approvals
AorticLab has received an expanded CE mark for its FLOWer embolic protection device, allowing broader use in transcatheter cardiovascular procedures beyond TAVI. The device is...

Get Weekly Newsletter

[hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

Finance

Funding

Clinical Trials

Imperative Care reports SYMPHONY-PE trial data for pulmonary embolism

Imperative Care has reported results from a post-hoc analysis of the SYMPHONY-PE trial, evaluating the impact of early mechanical thrombectomy in patients with intermediate-risk...

VahatiCor enrolls first U.S. patient in SERRA-I clinical study of A-FLUX Reducer System

VahatiCor has enrolled the first U.S. patient in its SERRA-I early feasibility study, evaluating the investigational A-FLUX Reducer System® for patients with coronary microvascular...

Raydiant Oximetry completes enrollment of First 15 Patients in IDE Pilot Study

Raydiant Oximetry has completed enrollment and data collection for the first 15 patients in its FDA-approved IDE pilot study at LSU Health Shreveport, advancing...

Airiver treats first patient in drug-coated balloon study for chronic rhinosinusitis

Airiver Medical has announced the first patient treatment in its RESTORE-2 pivotal clinical trial evaluating its ESSpand drug-coated balloon (DCB) for chronic rhinosinusitis (CRS). The...

Innovation

Regulatory Approvals

Carvolix secures new €10M tranche, bringing total financing to €20M

Carvolix has raised an additional €10 million tranche, bringing total funding under its €30 million financing programme to €20 million. The new capital reflects...

Tissium closes $68M financing for tissue reconstruction polymers

Tissium has raised $68 million (€60 million) through a combination of a $34 million Series D2 financing and a $34 million financing facility from...

Valgen earns CE mark for mitral valve repair system

Valgen Medtech has received CE mark approval for its DragonFly transcatheter mitral valve repair system for the treatment of functional mitral regurgitation (FMR), expanding...

AorticLab earns expanded CE mark for embolic protection device

AorticLab has received an expanded CE mark for its FLOWer embolic protection device, allowing broader use in transcatheter cardiovascular procedures beyond TAVI. The device is...

M&A

Archives

Latest articles

Load more

Popular categories

Funding1162Regulatory Approvals1032Innovation656Clinical Trials529Mergers & Acquisitions511GS Funding Tracker54